Elan raises price of MS drug Tysabri by 21%; Annual cost per ...

FinFacts Ireland - Ireland
Irish drugs firm Elan plans to raise the price of its multiple sclerosis treatment Tysabri by 21 percent when the drug returns to the market next month. ...

Elan Raises Tysabri Price as Drug Returns to Market (Update2)
Bloomberg - USA
will raise the price of its multiple sclerosis treatment Tysabri by 21 percent when the drug returns to pharmacy shelves next month. ...

Elan Raises Tysabri Price as Drug Returns to Market (Update3)
Bloomberg - USA
June 9 (Bloomberg) -- Elan Corp.'s Tysabri will be the most expensive multiple sclerosis treatment on the market when it returns next month, a year after the ...

Elan lifts Tysabri wholesale price
RTE.ie - Ireland
Pharmaceutical company Elan is to raise the wholesale price of its multiple sclerosis treatment Tysabri following its approval by US regulators earlier this ...

Price of Tysabri Increases
TheStreet.com - USA
The price of Tysabri, the newly reapproved multiple sclerosis drug from Biogen Idec (BIIB:Nasdaq - commentary - research - Cramer's Take) and Elan (ELN:NYSE ...

Elan's sets Tysabri pricing 22% above market forecasts
MarketWatch - USA
DUBLIN (MarketWatch) -- Irish drug company Elan Corp. (ELN) said Friday its multiple sclerosis drug Tysabri will have a wholesale price of $2,185 per 15 ...

FDA Approves Resumed Marketing of Tysabri Under a Special ...
Pharmaceutical Processing - Rockaway,NJ,USA
The FDA recently approved an application for resumed marketing of Tysabri (natalizumab) subject to a special restricted distribution program. ...

UPDATE 1-Elan raises price for Tysabri drug
Reuters - USA
DUBLIN, June 9 (Reuters) - Irish drugs company Elan (ELN.I: Quote, Profile, Research) announced its pricing plan for multiple sclerosis drug Tysabri on Friday ...

Tysabri Returns
6abc.com - Philadelphia,PA,USA
... on the market. The agency has given the green light to Tysabri, which is used to treat the relapsing forms of MS. Studies show the ...
See all stories on this topic